LT3168214T - Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdas - Google Patents
Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdasInfo
- Publication number
- LT3168214T LT3168214T LTEP15818878.9T LT15818878T LT3168214T LT 3168214 T LT3168214 T LT 3168214T LT 15818878 T LT15818878 T LT 15818878T LT 3168214 T LT3168214 T LT 3168214T
- Authority
- LT
- Lithuania
- Prior art keywords
- composition
- thyxo
- anticipal
- analoges
- imidazolidin
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014127705/04A RU2557235C1 (ru) | 2014-07-08 | 2014-07-08 | Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты |
| PCT/RU2015/000395 WO2016007046A1 (ru) | 2014-07-08 | 2015-06-26 | Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3168214T true LT3168214T (lt) | 2019-07-25 |
Family
ID=53611746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP15818878.9T LT3168214T (lt) | 2014-07-08 | 2015-06-26 | Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdas |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10450278B2 (lt) |
| EP (1) | EP3168214B1 (lt) |
| JP (1) | JP6581193B2 (lt) |
| KR (1) | KR102171120B1 (lt) |
| AU (1) | AU2015288381B2 (lt) |
| CA (1) | CA2954401C (lt) |
| CY (1) | CY1122231T1 (lt) |
| DK (1) | DK3168214T3 (lt) |
| ES (1) | ES2736507T3 (lt) |
| GE (1) | GEP20207096B (lt) |
| HR (1) | HRP20191265T8 (lt) |
| HU (1) | HUE044317T2 (lt) |
| LT (1) | LT3168214T (lt) |
| PL (1) | PL3168214T3 (lt) |
| PT (1) | PT3168214T (lt) |
| RS (1) | RS59009B1 (lt) |
| RU (1) | RU2557235C1 (lt) |
| SI (1) | SI3168214T1 (lt) |
| SM (1) | SMT201900379T1 (lt) |
| TR (1) | TR201910220T4 (lt) |
| UA (1) | UA117626C2 (lt) |
| WO (1) | WO2016007046A1 (lt) |
| ZA (1) | ZA201700922B (lt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3030181A1 (en) * | 2016-07-08 | 2018-01-11 | Janssen Pharmaceutica Nv | Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonists |
| CN107954936B (zh) * | 2016-10-17 | 2021-03-19 | 海创药业股份有限公司 | 一种制备氘代咪唑二酮类化合物的方法 |
| CN109422725A (zh) * | 2017-09-04 | 2019-03-05 | 北京美倍他药物研究有限公司 | 前列腺癌治疗药物 |
| RU2708253C2 (ru) * | 2017-12-05 | 2019-12-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Новые производные арил-тиогидантоина, ингибиторы андрогенового рецептора, способ получения и применения |
| BR112021011968A2 (pt) * | 2018-12-19 | 2021-09-08 | Celgene Corporation | Compostos de 3-((3-aminofenil)amino)piperidina-2,6-diona substituídos, composições dos mesmos e métodos de tratamento com os mesmos |
| TW202039434A (zh) * | 2018-12-19 | 2020-11-01 | 美商西建公司 | 經取代之3-((3-胺基苯基)胺基)哌啶-2,6-二酮化合物、其組合物及使用彼等之治療方法 |
| CN114621109B (zh) * | 2020-12-14 | 2024-04-26 | 成都苑东生物制药股份有限公司 | 一种阿帕他胺的合成方法及其中间体 |
| CN113698310B (zh) * | 2021-08-20 | 2023-03-17 | 江西金丰药业有限公司 | 一种恩杂鲁胺双酯中间体的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS53967B1 (sr) * | 2005-05-13 | 2015-08-31 | The Regents Of The University Of California | Diaril hidantoin jedinjenja kao antagonisti receptora androgena za lečenje raka |
| BRPI1007990A2 (pt) * | 2009-02-24 | 2015-09-01 | Medivation Prostate Therapeutics Inc | Compostos específicos de diaril-hidantoína e diariltioidantoína. |
| AU2011218173C1 (en) * | 2010-02-16 | 2015-04-16 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulators and uses thereof |
| SI3329775T1 (sl) * | 2010-02-24 | 2021-09-30 | Medivation Prostate Therapeutics Llc | Procesi za sintezo spojin diariltiohidantoina in diarilhidantoina |
| RU2434851C1 (ru) * | 2010-07-22 | 2011-11-27 | Александр Васильевич Иващенко | Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения |
| RU2520134C1 (ru) * | 2013-02-27 | 2014-06-20 | Общество с ограниченной ответственностью "Авионко" (ООО "Авионко") | Замещенные (r)-3-(4-метилкарбамоил-3-фторфениламино)-тетрагидро-фуран-3-енкарбоновые кислоты и их эфиры, способ их получения и применения |
-
2014
- 2014-07-08 RU RU2014127705/04A patent/RU2557235C1/ru active
-
2015
- 2015-06-26 PL PL15818878T patent/PL3168214T3/pl unknown
- 2015-06-26 WO PCT/RU2015/000395 patent/WO2016007046A1/ru not_active Ceased
- 2015-06-26 GE GEAP201514411A patent/GEP20207096B/en unknown
- 2015-06-26 TR TR2019/10220T patent/TR201910220T4/tr unknown
- 2015-06-26 US US15/324,658 patent/US10450278B2/en active Active
- 2015-06-26 KR KR1020177003384A patent/KR102171120B1/ko active Active
- 2015-06-26 RS RS20190891A patent/RS59009B1/sr unknown
- 2015-06-26 HR HRP20191265T patent/HRP20191265T8/hr unknown
- 2015-06-26 PT PT15818878T patent/PT3168214T/pt unknown
- 2015-06-26 AU AU2015288381A patent/AU2015288381B2/en active Active
- 2015-06-26 DK DK15818878.9T patent/DK3168214T3/da active
- 2015-06-26 SI SI201530801T patent/SI3168214T1/sl unknown
- 2015-06-26 ES ES15818878T patent/ES2736507T3/es active Active
- 2015-06-26 CA CA2954401A patent/CA2954401C/en not_active Expired - Fee Related
- 2015-06-26 UA UAA201700635A patent/UA117626C2/uk unknown
- 2015-06-26 EP EP15818878.9A patent/EP3168214B1/en active Active
- 2015-06-26 SM SM20190379T patent/SMT201900379T1/it unknown
- 2015-06-26 JP JP2017522315A patent/JP6581193B2/ja active Active
- 2015-06-26 LT LTEP15818878.9T patent/LT3168214T/lt unknown
- 2015-06-26 HU HUE15818878 patent/HUE044317T2/hu unknown
-
2017
- 2017-02-06 ZA ZA2017/00922A patent/ZA201700922B/en unknown
-
2019
- 2019-07-15 CY CY20191100752T patent/CY1122231T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170023184A (ko) | 2017-03-02 |
| JP2017522379A (ja) | 2017-08-10 |
| GEP20207096B (en) | 2020-04-10 |
| RU2557235C1 (ru) | 2015-07-20 |
| PT3168214T (pt) | 2019-07-25 |
| EP3168214A4 (en) | 2018-02-14 |
| EP3168214B1 (en) | 2019-04-24 |
| HRP20191265T8 (hr) | 2019-11-01 |
| WO2016007046A1 (ru) | 2016-01-14 |
| DK3168214T3 (da) | 2019-07-22 |
| SMT201900379T1 (it) | 2019-09-09 |
| US10450278B2 (en) | 2019-10-22 |
| US20180179164A1 (en) | 2018-06-28 |
| AU2015288381A1 (en) | 2017-03-02 |
| SI3168214T1 (sl) | 2019-09-30 |
| CA2954401A1 (en) | 2016-01-14 |
| KR102171120B1 (ko) | 2020-10-29 |
| UA117626C2 (uk) | 2018-08-27 |
| ES2736507T3 (es) | 2020-01-02 |
| RS59009B1 (sr) | 2019-08-30 |
| AU2015288381B2 (en) | 2019-11-07 |
| PL3168214T3 (pl) | 2019-10-31 |
| HUE044317T2 (hu) | 2019-10-28 |
| CY1122231T1 (el) | 2020-11-25 |
| ZA201700922B (en) | 2019-08-28 |
| HRP20191265T1 (hr) | 2019-10-18 |
| CA2954401C (en) | 2021-03-02 |
| TR201910220T4 (tr) | 2019-07-22 |
| EP3168214A1 (en) | 2017-05-17 |
| JP6581193B2 (ja) | 2019-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL260383B (en) | Low dose medication | |
| PH12016501139B1 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| LT2943192T (lt) | Kasos vėžio gydymo būdai, apimantys paklitakselį ir gemcitabiną | |
| LT3168214T (lt) | Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdas | |
| DK2986304T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf. | |
| BR112016018062A2 (pt) | compostos terapêuticos, composição farmacêutica e usos | |
| IL276733A (en) | Use of Aribolin in cancer treatment | |
| IL258246B (en) | Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer | |
| LT3200815T (lt) | Būdai ir kompozicijos, skirti vėžio gydymui | |
| LT3371179T (lt) | Nauji kriptoficino junginiai ir konjugatai, jų gavimas ir terapinis panaudojimas | |
| LT3069720T (lt) | Farmacinė kompozicija, kurios sudėtyje yra glutarimido dariniai, ir jų panaudojimas eozinofilinių ligų gydymui | |
| EP3581183A4 (en) | PHARMACEUTICAL COMPOSITION FOR ONCOTHERAPY | |
| LT4124339T (lt) | Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu | |
| SG11201605868XA (en) | Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient | |
| IL245738A0 (en) | Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases | |
| BR112017013012A2 (pt) | compostos de indenil, composições farmacêuticas e usos médicos destes | |
| IL249860A0 (en) | Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer | |
| ZA201608558B (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
| IL274177A (en) | Medical substances, their preparation and diagnostic method | |
| EP3153178A4 (en) | Method for treating cancer patients using folr1 targeted drug and antifolate, and drug | |
| IL251930A0 (en) | Anylhydroxy derivatives, their preparation and medical uses | |
| BR112018002732A2 (pt) | Agente terapêutico para tumor | |
| GB2553684B (en) | Ethynylxanthines, preparation and use for cancer treatment | |
| DK3092039T3 (da) | Hudcancerbehandling med strålingsterapi | |
| BR112017005002A2 (pt) | macropinocitose de anticorpos anti-cd46 humanos e agentes terapêuticos dirigidos contra o câncer. |